Summary:
An international research team has developed injectable, hollow semiconducting nanoparticles that function as microscopic light receptors inside degenerated eyes. When illuminated, these particles create a wireless interface that activates surviving retinal nerve cells, prompting visual signals to reach the brain and restoring measurable light responses in animal models of retinitis pigmentosa.
Key Facts:
- Microscopic photoreceptor substitutes: Hollow nanoparticles roughly 300 nanometers in diameter, made from graphitic carbon nitride, mimic chloroplast architecture to capture visible light and stimulate nearby retinal cells without genetic modification.
- Signals reach the brain: In mice with advanced retinitis pigmentosa, injections of these particles near retinal ganglion cells produced light-evoked electrical activity in the visual cortex and provoked measurable light-driven behaviors.
- Mutation-independent strategy: This approach recruits surviving native retinal neurons directly, avoiding the need for gene-specific therapies or viral delivery methods required by optogenetics.
Source: Aarhus University
Background: In neurodegenerative eye diseases like retinitis pigmentosa, photoreceptors that normally capture light progressively die, but deeper retinal neurons—including retinal ganglion cells—can remain viable. For years, engineers and neuroscientists have sought ways to bypass lost photoreceptors by stimulating these remaining neurons to re-establish light-driven visual signaling.
A multi-institutional study published in Nature Biomedical Engineering reports a major step forward: injectable, light-sensitive graphitic carbon nitride nanoparticles that restore light responsiveness in degenerated retinas in preclinical models.
Led by Associate Professor Menglin Chen at Aarhus University, the team engineered hollow-sphere graphitic carbon nitride nanoparticles (about 300 nm wide). Inspired by plant chloroplasts, the hollow architecture improves photon harvesting and supports efficient photoelectrochemical and photothermal responses under visible light.
“Our primary question was whether we could design a material that serves as a wireless interface between light and living neurons,” said Dr. Chen. “We now see that these particles can activate nerve cells in blind retinas, which brings us closer to a new type of retinal prosthesis.”
Activating the Visual Pathway in Blind Eyes
Under illumination, the graphitic carbon nitride nanoparticles generate localized physical and chemical changes that stimulate adjacent living cells. To test their potential as photoreceptor substitutes, researchers injected the particles into eyes of mice with advanced retinal degeneration. The nanoparticles settled on the retinal surface close to retinal ganglion cells, the neurons that transmit visual information to the brain.
When light was applied, the investigators recorded clear evoked electrical activity in the mice’s visual cortex, demonstrating that light-driven signals propagated from the retina to the brain. The treated mice also displayed measurable behavioral responses to light. The team further validated functionality using ex vivo porcine retinal tissue, where the nanoparticles directly activated retinal ganglion cell activity under LED photostimulation.
“Rather than genetically altering surviving cells, we use nanoparticles to create a direct physical connection between incoming light and native neurons,” Chen explained. “This approach aims to make a blind retina respond to light again by leveraging the neurons that remain functional.”
A Mutation-Agnostic Horizon for Vision Restoration
Existing strategies for restoring vision have important limitations. Electronic retinal implants often involve invasive surgery and hardware burdens. Gene therapies can address specific mutations but are limited by genetic heterogeneity. Optogenetic approaches require genetic modification with viral vectors. By contrast, this nanoparticle-based method is mutation-agnostic and uses the retina’s surviving circuitry to transduce light into neural signals.
“Options for restoring light sensitivity after photoreceptor loss remain limited, and each current approach has trade-offs,” said co-author and retina specialist Henri Leinonen. “Our results show a light-evoked response in a degenerated retina—an important early milestone, even though this is not yet a complete prosthetic solution.”
While the technology does not restore normal acuity or full vision, the findings establish that microscopic “photovoltaic” particles can form an effective wireless link with degenerated mammalian neural circuits. The research team has filed international patent applications and is investigating long-term ocular biocompatibility, delivery methods, and particle stability as steps toward potential human clinical trials.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by staff.
About this Genetics and Neuroregeneration Research:
- Media Contact: Jesper Bruun
- Source: Aarhus University
- Image Credit: Image credited to Neuroscience News
- Original Research is Open Access: Nature Biomedical Engineering (September 22, 2026). Title: “Biomimetic graphitic carbon nitride nanoparticles for multiscale photomodulation and therapeutic intervention.” Authors: Christoph Alexander Müller, Kjeld Kaj Klompmaker, Yuge Zhang, Jing Zhang, Anna Kalatanova, Pengjiu Li, Lingyuan Meng, Jesper Guldsmed Madsen, Thomas Stax Jakobsen, Asbjørn C. Jørgensen, Anne Louise Askou, Yonglun Luo, Lin Lin, Sara Vogt Bleshøy, Georgios Bolis, Ge Huang, Wen Li, Rasmus Schmidt Davidsen, Toke Bek, Nikos S. Hatzakis, Thomas J. Corydon, Henri Leinonen, Bozhi Tian, Mingdong Dong & Menglin Chen.
- DOI: 10.1038/s41551-026-01773-w
Abstract
Biomimetic graphitic carbon nitride nanoparticles for multiscale photomodulation and therapeutic intervention
Drawing inspiration from photosynthesis, the authors developed hollow-sphere graphitic carbon nitride nanoparticles (hg-C3N4 NPs) capable of modulating biological activity from subcellular processes to whole-tissue function. These homogeneous hollow nanoparticles respond to visible light through both photoelectrochemical and photothermal mechanisms and show excellent cytocompatibility with spontaneous cellular uptake.
Using focused laser light, the hg-C3N4 NPs enable intracellular optical stimulation with subcellular resolution, triggering calcium transients and signal propagation in primary cardiomyocytes and cardiac fibroblasts. At the tissue level, light-emitting diodes achieve optical pacing and synchronization of cardiomyocyte beating. Critically, the nanoparticles can be delivered safely to the eye and evoke measurable cortical and behavioral light responses in a model of advanced retinal degeneration.
Ex vivo application to porcine retinal tissue confirms that hg-C3N4 NPs directly activate retinal ganglion cell activity under LED photostimulation. Together, these results position hg-C3N4 nanoparticles as a versatile tool for addressing biomedical challenges through precise photo-modulation across subcellular, intercellular, and tissue scales.